4th Quarter - Report
W STRATEGIES, LLC for ALEXION PHARMACEUTICALS
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Education about reimbursement for orphan drug therapies in skilled nursing facilities and proposed add-on payments in inpatient hospitals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Taxation/Internal Revenue Code TAX
H.R.1/S.1: Tax Cuts and Jobs Act, as it relates to the Orphan Drug Tax Credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Education about the value of innovative new medicines and the Orphan Drug Act. H.R.3922: CHAMPIONING HEALTHY KIDS Act. H.R.4679: Ensuring Equal Access to Treatments Act of 2017. Education about the 340(b) program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.